It is a metabolic disorder in the body in which the ability to produce insulin is lost, or the body becomes resistant to insulin, resulting in high blood sugar. The global prevalence of type 2 diabetes for all age groups was approximately 2.8% in the year 2000, while it is estimated that this figure will reach 4.4% by 2030, and the total number of people with type 2 diabetes will reach 336 million by 2030. This disease has affected between 6 and 10 percent of the Iranian population, and when including those at risk of diabetes in the country, this percentage becomes significant. In the management of this disease, lifestyle changes including proper diet, exercise, and the use of blood sugar-lowering medications should be considered. Due to the side effects of drugs, researchers are encouraged to explore new methods and discover more suitable ways to control the disease and its complications. Given the aforementioned problems, reducing sugar consumption and using sugar substitutes has been proposed to lower blood sugar and calorie intake in the human body, making it suitable for obese and diabetic individuals.

In this regard, this company, as one of the pioneers of this industry and the only manufacturer of polyol sugars (sugar alcohols) in Iran, after extensive research in 2014 (1393 Persian calendar), succeeded in producing these types of products in powder and liquid forms.